The effects of chromium(VI) on the thioredoxin system: Implications for redox regulation

Free Radical Biology and Medicine

Volumn 52, Issue 10, 2012, Pages 2091-2107

  Myers, Charles R ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b FREE RADICAL RESEARCH CENTER   (United States)

Author keywords

Chromium(VI); Free radicals; Peroxiredoxin; Redox signaling; Thiol oxidation; Thioredoxin; Thioredoxin reductase

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; AURANOFIN; CHROMIUM; ELECTROPHILE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOCHONDRIAL DNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXIREDOXIN; PEROXIREDOXIN 1; PEROXIREDOXIN 3; PROTEIN P53; THIOREDOXIN 1; THIOREDOXIN 2; THIOREDOXIN REDUCTASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2;

APOPTOSIS; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL SURVIVAL; DNA BINDING; DNA DAMAGE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAMMAL CELL; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; REDOX STRESS; REVIEW; UPREGULATION;

ANIMALS; CHROMIUM; HUMANS; MICE; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASES; NF-E2-RELATED FACTOR 2; NF-KAPPA B; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIREDOXINS; THIOREDOXIN-DISULFIDE REDUCTASE; THIOREDOXINS; TRANSCRIPTION FACTOR AP-1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84861058076     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.03.013     Document Type: Review

References (263)

1. Becker, N.; Chang-Claude, J.; Frentzel-Beyme, R. Risk of cancer for arc welders in the Federal Republic of Germany: results of a second follow up (1983-8). Br. J. Ind. Med. 48:675-683; 1991.
2. Ishikawa, Y.; Nakagawa, K.; Satoh, Y.; Kitagawa, T.; Sugano, H.; Hirano, T.; Tsuchiya, E. Characteristics of chromate workers' cancers, chromium lung deposition and precancerous bronchial lesions: an autopsy study. Br. J. Cancer 70:160-166; 1994.
3. Nakagawa, K.; Matsubara, T.; Kinoshita, I.; Tsuchiya, E.; Sugano, H.; Hirano, T. Surveillance study of a group of chromate workers - early detection and high incidence of lung cancer. Lung Cancer 24:301-310; 1984. (in Japanese).
4. Franchini, I.; Magnani, F.; Mutti, A. Mortality experience among chromplating workers. Scand. J. Work Environ. Health 9:247-252; 1983.
5. Deschamps, F.; Moulin, J. J.; Wild, P.; Labriffe, H.; Haguenoer, J. M. Mortality study among workers producing chromate pigments in France. Int. Arch. Occup. Environ. Health 67:147-152; 1995.
6. Baruthio, F. Toxic effects of chromium and its compounds. Biol. Trace Elem. Res. 32:145-153; 1992.
7. Bright, P.; Burge, P. S.; O'Hickey, S. P.; Gannon, P. F.; Robertson, A. S.; Boran, A. Occupational asthma due to chrome and nickel electroplating. Thorax 52:28-32; 1997.
8. Park, H. S.; Yu, H. J.; Jung, K. S. Occupational asthma caused by chromium. Clin. Exp. Allergy 24:676-681; 1994.
9. Occupational Safety and Health Administration. Occupational exposure to hexavalent chromium: final rule. Fed. Regist. 71:10099-10385; 2006.
10. Shelnutt, S. R.; Goad, P.; Belsito, D. V. Dermatological toxicity of hexavalent chromium. Crit. Rev. Toxicol. 37:375-387; 2007.
11. Nethercott, J.; Paustenbach, D.; Adams, R.; Fowler, J.; Marks, J.; Morton, C.; Taylor, J.; Horowitz, S.; Finley, B. A study of chromium induced allergic contact dermatitis with 54 volunteers: implications for environmental risk assessment. Occup. Environ. Med. 51:371-380; 1994.
12. Gadd, G. M.; White, C. Microbial treatment of metal pollution - a working biotechnology? TIBTECH 11; 1993.
13. Environmental Protection Agency. Chromium. Washington, DC: Office of Health and Environmental Assessment, U.S. EPA; 1999.
14. Zhitkovich, A.; Voitkun, V.; Kluz, T.; Costa, M. Utilization of DNA-protein cross-links as a biomarker of chromium exposure. Environ. Health Perspect. 106(Suppl. 4):969-974; 1998.
15. Fagliano, J. A.; Savrin, J.; Udasin, I.; Gochfeld, M. Community exposure and medical screening near chromium waste sites in New Jersey. Regul. Toxicol. Pharmacol. 26:S13-S22; 1997.
16. Costa, M. Toxicity and carcinogenicity of Cr(VI) in animal models and humans. Crit. Rev. Toxicol. 27:431-442; 1997.
17. Calder, L. M. Chromium contamination of groundwater. In: Nriagu, J. O., Nieboer, E., editors. Chromium in the Natural and Human Environments. New York: Wiley; 1988. p. 215-229.
18. Cohen, M. D.; Kargacin, B.; Klein, C. B.; Costa, M. Mechanisms of chromium carcinogenicity and toxicity. Crit. Rev. Toxicol. 23:255-281; 1993.
19. Martin, R. B. Bioinorganic chemistry of metal ion toxicity. In: Sigel, H., editor. Metal Ions in Biological Systems. New York: Dekker; 1986. p. 21-65.
20. Buttner, B.; Beyersmann, D. Modification of the erythrocyte anion carrier by chromate. Xenobiotica 15:735-741; 1985.
21. Elias, Z.; Poirot, O.; Baruthio, F.; Daniere, M. C. Role of solubilized chromium in the induction of morphological transformation of Syrian hamster embryo (SHE) cells by particulate chromium(VI) compounds. Carcinogenesis 12:1811-1816; 1991.
22. Wise, S. S.; Holmes, A. L.; Ketterer, M. E.; Hartsock, W. J.; Fomchenko, E.; Katsifis, S.; Thompson, W. D.; Wise Sr. J. P. Chromium is the proximate clastogenic species for lead chromate-induced clastogenicity in human bronchial cells. Mutat. Res. 560:79-89; 2004.
23. Wise, J. P. S.; Stearns, D. M.; Wetterhahn, K. E.; Patierno, S. R. Cell-enhanced dissolution of carcinogenic lead chromate particles: the role of individual dissolution products in clastogenesis. Carcinogenesis 15:2249-2254; 1994.
24. Leonard, A.; Lauwerys, R. R. Carcinogenicity and mutagenicity of chromium. Mutat. Res. 76:227-239; 1980.
25. Xie, H.; Holmes, A. L.; Wise, S. S.; Gordon, N.; Wise Sr. J. P. Lead chromate-induced chromosome damage requires extracellular dissolution to liberate chromium ions but does not require particle internalization or intracellular dissolution. Chem. Res. Toxicol. 17:1362-1367; 2004.
26. Borthiry, G. R.; Antholine, W. E.; Myers, J. M.; Myers, C. R. Reductive activation of hexavalent chromium by human lung epithelial cells: generation of Cr(V) and Cr(V)-thiol species. J. Inorg. Biochem. 102:1449-1462; 2008.
27. Xie, H.; Holmes, A. L.; Young, J. L.; Qin, Q.; Joyce, K.; Pelsue, S. C.; Peng, C.; Wise, S. S.; Jeevarajan, A. S.; Wallace, W. T.; Hammond, D.; Wise Sr. J. P. Zinc chromate induces chromosome instability and DNA double strand breaks in human lung cells. Toxicol. Appl. Pharmacol. 234:293-299; 2009.
28. Patierno, S. R.; Banh, D.; Landolph, J. R. Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particles. Cancer Res. 48:5280-5288; 1988.
29. Biedermann, K. A.; Landolph, J. R. Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts. Cancer Res. 47:3815-3823; 1987.
30. Biedermann, K. A.; Landolph, J. R. Role of valence state and solubility of chromium compounds on induction of cytotoxicity, mutagenesis, and anchorage independence in diploid human fibroblasts. Cancer Res. 50:7835-7842; 1990.
31. Nickens, K. P.; Patierno, S. R.; Ceryak, S. Chromium genotoxicity: a double-edged sword. Chem.-Biol. Interact. 188:276-288; 2010.
32. Whiting, R. F.; Stich, H. F.; Koropatnick, D. J. DNA damage and DNA repair in cultured human cells exposed to chromate. Chem.-Biol. Interact. 26:267-280; 1979.
33. Tsapakos, M. J.; Hampton, T. H.; Wetterhahn, K. E. Chromium(VI)-induced DNA lesions and chromium distribution on rat kidney, liver and lung. Cancer Res. 43:5662-5667; 1983.
34. Levy, L. S.; Venitt, S. Carcinogenicity and mutagenicity of chromium compounds: the association between bronchial metaplasia and neoplasia. Carcinogenesis 7:831-835; 1986.
35. Christie, N. T.; Cantoni, O.; Evans, R. M.; Meyn, R. E.; Costa, M. Use of mammalian DNA repair-deficient mutants to assess the effects of toxic metal compounds on DNA. Biochem. Pharmacol. 33:1661-1670; 1984.
36. Cantoni, O.; Costa, M. Analysis of the induction of alkali sensitive sites in the DNA by chromate and other agents that induce single strand breaks. Carcinogenesis 5:1207-1209; 1984.
37. Standeven, A. M.; Wetterhahn, K. E. Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro. Carcinogenesis 13:1319-1324; 1992.
38. Shi, X.; Dong, Z.; Dalal, N. S.; Gannett, P. M. Chromate-mediated free radical generation from cysteine, penicillamine, hydrogen peroxide, and lipid hydroperoxides. Biochim. Biophys. Acta 1226:65-72; 1994.
39. Shi, X. L.; Dalal, N. S. One-electron reduction of chromate by NADPH-dependent glutathione reductase. J. Inorg. Biochem. 40:1-12; 1990.
40. Suzuki, Y.; Fukuda, K. Reduction of hexavalent chromium by ascorbic acid and glutathione with special reference to the rat lung. Arch. Toxicol. 64:169-176; 1990.
41. 5: generation of hydroxyl radical and superoxide. Free Radic. Biol. Med. 42:738-755; 2007.
42. Myers, C. R.; Myers, J. M.; Carstens, B. P.; Antholine, W. E. Reduction of chromium(VI) to chromium(V) by human microsomal enzymes: effects of iron and quinones. Toxic Subst. Mech. 19:25-51; 2000.
43. Jannetto, P. J.; Antholine, W. E.; Myers, C. R. Cytochrome b5 plays a key role in human microsomal chromium(VI) reduction. Toxicology 159:119-133; 2001.
44. Kortenkamp, A.; Beyersmann, D.; O'Brien, P. Uptake of chromium(III) complexes by erythrocytes. Toxicol. Environ. Chem. 14:23-32; 1987.
45. Jennette, K. W. Microsomal reduction of the carcinogen chromate produces chromium(V). J. Am. Chem. Soc. 104:874-875; 1982.
46. Liu, K. J.; Shi, X. In vivo reduction of chromium (VI) and its related free radical generation. Mol. Cell. Biochem. 222:41-47; 2001.
47. Liebross, R. H.; Wetterhahn, K. E. In vivo formation of chromium(V) in chick embryo liver and red blood cells. Carcinogenesis 13:2113-2120; 1992.
48. Myers, C. R.; Antholine, W. E.; Myers, J. M. The pro-oxidant chromium(VI) inhibits mitochondrial complex I, complex II, and aconitase in the bronchial epithelium: EPR markers for Fe-S proteins. Free Radic. Biol. Med. 49:1903-1915; 2010.
49. Liu, K. J.; Jiang, J.; Swartz, H. M.; Shi, X.; Low-frequency, E. P. R. detection of chromium(V) formation by chromium(VI) reduction in whole live mice. Arch. Biochem. Biophys. 313:248-252; 1994.
50. Ueno, S.; Kashimoto, T.; Susa, N.; Furukawa, Y.; Ishii, M.; Yokoi, K.; Yasuno, M.; Sasaki, Y. F.; Ueda, J.; Nishimura, Y.; Sugiyama, M. Detection of dichromate (VI)-induced DNA strand breaks and formation of paramagnetic chromium in multiple mouse organs. Toxicol. Appl. Pharmacol. 170:56-62; 2001.
51. Sugiyama, M.; Tsuzuki, K.; Haramaki, N. Influence of o-phenanthroline on DNA single-strand breaks, alkali-labile sites, glutathione reductase, and formation of chromium(V) in Chinese hamster V-79 cells treated with sodium chromate(VI). Arch. Biochem. Biophys. 305:261-266; 1993.
52. Stearns, D. M.; Kennedy, L. J.; Courtney, K. D.; Giangrande, P. H.; Phieffer, L. S.; Wetterhahn, K. E. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. Biochemistry 34:910-919; 1995.
53. Stearns, D. M.; Wetterhahn, K. E. Reaction of chromium(VI) with ascorbate produces chromium(V), chromium(IV), and carbon-based radicals. Chem. Res. Toxicol. 7:219-230; 1994.
54. Dillon, C. T.; Lay, P. A.; Bonin, A. M.; Cholewa, M.; Legge, G. J. F.; Collins, T. J.; Kostka, K. L. Permeability, cytotoxicity, and genotoxicity of chromium(V) and chromium(VI) complexes in V79 Chinese hamster lung cells. Chem. Res. Toxicol. 11:119-129; 1998.
55. Standeven, A. M.; Wetterhahn, K. E. Is there a role for reactive oxygen species in the mechanism of chromium(VI) carcinogenesis? Chem. Res. Toxicol. 4:616-625; 1991.
56. Sugden, K. D.; Campo, C. K.; Martin, B. D. Direct oxidation of guanine and 7,8-dihydro-8-oxoguanine in DNA by a high-valent chromium complex: a possible mechanism for chromate genotoxicity. Chem. Res. Toxicol. 14:1315-1322; 2001.
57. Sugden, K. D. Formation of modified cleavage termini from the reaction of chromium(V) with DNA. J. Inorg. Biochem. 77:177-183; 1999.
58. Shi, X.; Dalal, N. S. NADPH-dependent flavoenzymes catalyze one electron reduction of metal ions and molecular oxygen and generate hydroxyl radicals. FEBS Lett. 276:189-191; 1990.
59. Shi, X.; Mao, Y.; Knapton, A. D.; Ding, M.; Rojanasakul, Y.; Gannett, P. M.; Dalal, N.; Liu, K. Reaction of Cr(VI) with ascorbate and hydrogen peroxide generates hydroxyl radicals and causes DNA damage: role of a Cr(IV)-mediated Fenton-like reaction. Carcinogenesis 15:2475-2478; 1994.
60. Luo, H.; Lu, Y.; Shi, X.; Mao, Y.; Dalal, N. S. Chromium(IV)-mediated Fenton-like reaction causes DNA damage: implication to genotoxicity of chromate. Ann. Clin. Lab. Sci. 26:185-191; 1996.
61. Tsou, T. -C.; Yang, J. -L. Formation of reactive oxygen species and DNA strand breakage during interaction of chromium(III) and hydrogen peroxide in vitro: evidence for a chromium(III)-mediated Fenton-like reaction. Chem.-Biol. Interact. 102:133-153; 1996.
62. Chen, F.; Ye, J.; Zhang, X.; Rojanasakul, Y.; Shi, X. One-electron reduction of chromium(VI) by α-lipoic acid and related hydroxyl radical generation, dG hydroxylation and nuclear transcription factor-κB activation. Arch. Biochem. Biophys. 338:165-172; 1997.
63. Leonard, S.; Wang, S.; Zang, L.; Castranova, V.; Vallyathan, V.; Shi, X. Role of molecular oxygen in the generation of hydroxyl and superoxide anion radicals during enzymatic Cr(VI) reduction and its implication to Cr(VI)-induced carcinogenesis. J. Environ. Pathol. Toxicol. Oncol. 19:49-60; 2000.
64. Shi, X.; Chiu, A.; Chen, C. T.; Halliwell, B.; Castranova, V.; Vallyathan, V. Reduction of chromium(VI) and its relationship to carcinogenesis. J. Toxicol. Environ. Health B 2:87-104; 1999.
65. Porter, R.; Jachymova, M.; Martasek, P.; Kalyanaraman, B.; Vasquez-Vivar, J. Reductive activation of Cr(VI) by nitric oxide synthase. Chem. Res. Toxicol. 18:834-843; 2005.
66. Pritchard Jr K. A.; Ackerman, A.; Kalyanaraman, B. Chromium(VI) increases endothelial cell expression of ICAM-1 and decreases nitric oxide activity. J. Environ. Pathol. Toxicol. Oncol. 19:251-260; 2000.
67. Wang, B. J.; Sheu, H. M.; Guo, Y. L.; Lee, Y. H.; Lai, C. S.; Pan, M. H.; Wang, Y. J. Hexavalent chromium induced ROS formation, Akt, NF-κB, and MAPK activation, and TNF-α and IL-1α production in keratinocytes. Toxicol. Lett. 198:216-224; 2010.
68. Gao, N.; Jiang, B. H.; Leonard, S. S.; Corum, L.; Zhang, Z.; Roberts, J. R.; Antonini, J.; Zheng, J. Z.; Flynn, D. C.; Castranova, V.; Shi, X. p38 Signaling-mediated hypoxia-inducible factor 1α and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells. J. Biol. Chem. 277:45041-45048; 2002.
69. Shi, X.; Ding, M.; Ye, J.; Wang, S.; Leonard, S. S.; Zang, L.; Castranova, V.; Vallyathan, V.; Chiu, A.; Dalal, N.; Liu, K. Cr(IV) causes activation of nuclear transcription factor-κB, DNA strand breaks and dG hydroxylation via free radical reactions. J. Inorg. Biochem. 75:37-44; 1999.
70. Sugiyama, M. Effects of vitamins on chromium(VI)-induced damage. Environ. Health Perspect. 92:63-70; 1991.
71. Molyneux, M. J.; Davies, M. J. Direct evidence for hydroxyl radical-induced damage to nucleic acids by chromium(VI)-derived species. Carcinogenesis 16:875-882; 1995.
72. Gao, M.; Binks, S. P.; Chipman, J. K.; Levy, L. S.; Braithwaite, R. A.; Brown, S. S. Induction of DNA strand breaks in peripheral lymphocytes by soluble chromium compounds. Hum. Exp. Toxicol. 11:77-82; 1992.
73. Taioli, E.; Zhitkovich, A.; Kinney, P.; Udasin, I.; Toniolo, P.; Costa, M. Increased DNA-protein crosslinks in lymphocytes of residents living in chromium-contaminated areas. Biol. Trace Elem. Res. 50:175-180; 1995.
74. 2-isoprostanes in vivo by acute Cr(VI) poisoning. Chem. Res. Toxicol. 11:1516-1520; 1998.
75. Popper, H. H.; Woldrich, A. Oxygen radical formation a probable mechanism for chromate toxicity. In: Graumann, W., Drukker, J., editors. Histo- and Cytochemistry as a Tool in Environmental Toxicology. New York: Fischer; 1991. p. 220-226.
76. Arreola-Mendoza, L.; Reyes, J. L.; Melendez, E.; Martin, D.; Namorado, M. C.; Sanchez, E.; Del Razo, L. M. α-Tocopherol protects against the renal damage caused by potassium dichromate. Toxicology 218:237-246; 2006.
77. Pourahmad, J.; Rabiei, M.; Jokar, F.; O'Brien, P. J. A comparison of hepatocyte cytotoxic mechanisms for chromate and arsenite. Toxicology 206:449-460; 2005.
78. Myers, J. M.; Myers, C. R. The effects of hexavalent chromium on thioredoxin reductase and peroxiredoxins in human bronchial epithelial cells. Free Radic. Biol. Med. 47:1477-1485; 2009.
79. Myers, J. M.; Antholine, W. E.; Myers, C. R. The intracellular redox stress caused by hexavalent chromium is selective for proteins that have key roles in cell survival and thiol redox control. Toxicology 281:37-47; 2011.
80. Myers, J. M.; Antholine, W. E.; Myers, C. R. Hexavalent chromium causes the oxidation of thioredoxin in human bronchial epithelial cells. Toxicology 246:222-233; 2008.
81. Pritchard, D. E.; Ceryak, S.; Ha, L.; Fornsaglio, J. L.; Hartman, S. K.; O'Brien, T. J.; Patierno, S. R. Mechanism of apoptosis and determination of cellular fate in chromium(VI)-exposed populations of telomerase-immortalized human fibroblasts. Cell Growth Differ. 12:487-496; 2001.
82. Pritchard, D. E.; Singh, J.; Carlisle, D. L.; Patierno, S. R. Cyclosporin A inhibits chromium(VI)-induced apoptosis and mitochondrial cytochrome c release and restores clonogenic survival in CHO cells. Carcinogenesis 21:2027-2033; 2000.
83. Rudolf, E.; Cervinka, M.; Cerman, J.; Schroterova, L. Hexavalent chromium disrupts the actin cytoskeleton and induces mitochondria-dependent apoptosis in human dermal fibroblasts. Toxicol. in Vitro 19:713-723; 2005.
84. Aiyar, J.; Berkovits, H. J.; Floyd, R. A.; Wetterhahn, K. E. Reaction of chromium(VI) with hydrogen peroxide in the presence of glutathione: reactive intermediates and resulting DNA damage. Chem. Res. Toxicol. 3:595-603; 1990.
85. Wang, S.; Leonard, S. S.; Ye, J.; Gao, N.; Wang, L.; Shi, X. Role of reactive oxygen species and Cr(VI) in Ras-mediated signal transduction. Mol. Cell. Biochem. 255:119-127; 2004.
86. Azad, N.; Iyer, A. K.; Manosroi, A.; Wang, L.; Rojanasakul, Y. Superoxide-mediated proteasomal degradation of Bcl-2 determines cell susceptibility to Cr(VI)-induced apoptosis. Carcinogenesis 29:1538-1545; 2008.
87. Ye, J.; Wang, S.; Leonard, S. S.; Sun, Y.; Butterworth, L.; Antonini, J.; Ding, M.; Rojanasakul, Y.; Vallyathan, V.; Castranova, V.; Shi, X. Role of reactive oxygen species and p53 in chromium(VI)-induced apoptosis. J. Biol. Chem. 274:34974-34980; 1999.
88. Son, Y. O.; Hitron, J. A.; Wang, X.; Chang, Q.; Pan, J.; Zhang, Z.; Liu, J.; Wang, S.; Lee, J. C.; Shi, X. Cr(VI) induces mitochondrial-mediated and caspase-dependent apoptosis through reactive oxygen species-mediated p53 activation in JB6 Cl41 cells. Toxicol. Appl. Pharmacol. 245:226-235; 2010.
89. Shi, X.; Sun, X.; Gannett, P. M.; Dalal, N. S. Deferoxamine inhibition of Cr(V)-mediated radical generation and deoxyguanine hydroxylation: ESR and HPLC evidence. Arch. Biochem. Biophys. 293:281-286; 1992.
90. Arreola-Mendoza, L.; Del Razo, L. M.; Mendoza-Garrido, M. E.; Martin, D.; Namorado, M. C.; Calderon-Salinas, J. V.; Reyes, J. L. The protective effect of α-tocopherol against dichromate-induced renal tight junction damage is mediated via ERK1/2. Toxicol. Lett. 191:279-288; 2009.
91. Molina-Jijón, E.; Tapia, E.; Zazueta, C.; El Hafidi, M.; Zatarain-Barrón, Z. L.; Hernández-Pando, R.; Medina-Campos, O. N.; Zarco-Márquez, G.; Torres, I.; Pedraza-Chaverri, J. Curcumin prevents Cr(VI)-induced renal oxidant damage by a mitochondrial pathway. Free Radic. Biol. Med. 51:1543-1557; 2011.
92. Szabo, C.; Day, B. J.; Salzman, A. L. Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavenger. FEBS Lett. 381:82-86; 1996.
93. Batinic-Haberle, I.; Cuzzocrea, S.; Reboucas, J. S.; Ferrer-Sueta, G.; Mazzon, E.; Di Paola, R.; Radi, R.; Spasojevic, I.; Benov, L.; Salvemini, D. Pure MnTBAP selectively scavenges peroxynitrite over superoxide: comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenan- induced pleurisy. Free Radic. Biol. Med. 46:192-201; 2009.
94. Zhang, Z.; Leonard, S. S.; Wang, S.; Vallyathan, V.; Castranova, V.; Shi, X. Cr(VI) induces cell growth arrest through hydrogen peroxide-mediated reactions. Mol. Cell. Biochem. 222:77-83; 2001.
95. Nkabyo, Y. S.; Ziegler, T. R.; Gu, L. H.; Watson, W. H.; Jones, D. P. Glutathione and thioredoxin redox during differentiation in human colon epithelial (Caco-2) cells. Am. J. Physiol. Gastrointest. Liver Physiol. 283:G1352-G1359; 2002.
96. Hansen, J. M.; Go, Y. M.; Jones, D. P. Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling. Annu. Rev. Pharmacol. Toxicol. 46:215-234; 2006.
97. Go, Y. M.; Jones, D. P. Redox compartmentalization in eukaryotic cells. Biochim. Biophys. Acta 1780:1273-1290; 2008.
98. Arnér, E. S. J.; Holmgren, A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267:6102-6109; 2000.
99. Winterbourn, C. C.; Hampton, M. B. Thiol chemistry and specificity in redox signaling. Free Radic. Biol. Med. 45:549-561; 2008.
100. Wiegand, H. J.; Ottenwälder, H.; Bolt, H. M. The reduction of chromium(VI) to chromium(III) by glutathione: an intracellular redox pathway in the metabolism of the carcinogen chromate. Toxicology 33:341-348; 1984.
101. Connett, P. H.; Wetterhahn, K. E. In vitro reaction of the carcinogen chromate with cellular thiols and carboxylic acids. J. Am. Chem. Soc. 107:4282-4288; 1985.
102. O'Brien, T.; Xu, J.; Patierno, S. R. Effects of glutathione on chromium-induced DNA crosslinking and DNA polymerase arrest. Mol. Cell. Biochem. 222:173-182; 2001.
103. Quinteros, F. A.; Machiavelli, L. I.; Miler, E. A.; Cabilla, J. P.; Duvilanski, B. H. Mechanisms of chromium (VI)-induced apoptosis in anterior pituitary cells. Toxicology 249:109-115; 2008.
104. Dubrovskaya, V. A.; Wetterhahn, K. E. Effects of Cr(VI) on the expression of the oxidative stress genes in human lung cells. Carcinogenesis 19:1401-1407; 1998.
105. Standeven, A. M.; Wetterhahn, K. E. Possible role of glutathione in chromium(VI) metabolism and toxicity in rats. Pharmacol. Toxicol. 68:469-476; 1991.
106. Fernandes, M. A.; Mota, I. M.; Silva, M. T.; Oliveira, C. R.; Geraldes, C. F.; Alpoim, M. C. Human erythrocytes are protected against chromate-induced peroxidation. Ecotoxicol. Environ. Saf. 43:38-46; 1999.
107. Pourahmad, J.; O'Brien, P. J. Biological reactive intermediates that mediate chromium(VI) toxicity. Adv. Exp. Med. Biol. 500:203-207; 2001.
108. Lalaouni, A.; Henderson, C.; Kupper, C.; Grant, M. H. The interaction of chromium(VI) with macrophages: depletion of glutathione and inhibition of glutathione reductase. Toxicology 236:76-81; 2007.
109. Joseph, P.; He, Q.; Umbright, C. Heme-oxygenase 1 gene expression is a marker for hexavalent chromium-induced stress and toxicity in human dermal fibroblasts. Toxicol. Sci. 103:325-334; 2008.
110. Lay, P. A.; Levina, A. Activation of molecular oxygen during the reactions of chromium(VI/V/IV) with biological reductants: implications for chromium-induced genotoxicities. J. Am. Chem. Soc. 120:6704-6714; 1998.
111. Hansen, R. E.; Roth, D.; Winther, J. R. Quantifying the global cellular thiol-disulfide status. Proc. Natl. Acad. Sci. USA 106:422-427; 2009.
112. Carvalho, A. T.; Fernandes, P. A.; Ramos, M. J. Determination of the DpKa between the active site cysteines of thioredoxin and DsbA. J. Comput. Chem. 27:966-975; 2006.
113. Jacob, C.; Giles, G. I.; Giles, N. M.; Sies, H. Sulfur and selenium: the role of oxidation state in protein structure and function. Angew. Chem. Int. Ed. Engl. 42:4742-4758; 2003.
114. Johansson, L.; Gafvelin, G.; Arnér, E. S. Selenocysteine in proteins - properties and biotechnological use. Biochim. Biophys. Acta 1726:1-13; 2005.
115. Arnér, E. S. Selenoproteins-what unique properties can arise with selenocysteine in place of cysteine? Exp. Cell Res. 316:1296-1303; 2010.
116. Arnér, E. S. Focus on mammalian thioredoxin reductases - important selenoproteins with versatile functions. Biochim. Biophys. Acta 495-526:2009; 1790.
117. Nordberg, J.; Arnér, E. S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31:1287-1312; 2001.
118. Cheng, Q.; Sandalova, T.; Lindqvist, Y.; Arnér, E. S. Crystal structure and catalysis of the selenoprotein thioredoxin reductase 1. J. Biol. Chem. 284:3998-4008; 2009.
119. Cheng, Q.; Antholine, W. E.; Myers, J. M.; Kalyanaraman, B.; Arnér, E. S.; Myers, C. R. The selenium-independent inherent pro-oxidant NADPH oxidase activity of mammalian thioredoxin reductase and its selenium-dependent direct peroxidase activities. J. Biol. Chem. 285:21708-21723; 2010.
120. Sandalova, T.; Zhong, L.; Lindqvist, Y.; Holmgren, A.; Schneider, G. Three-dimensional structure of a mammalian thioredoxin reductase: implications for mechanism and evolution of a selenocysteine-dependent enzyme. Proc. Natl. Acad. Sci. USA 98:9533-9538; 2001.
121. Arnér, E. S.; Bjornstedt, M.; Holmgren, A. 1-Chloro-2,4- dinitrobenzene is an irreversible inhibitor of human thioredoxin reductase: loss of thioredoxin disulfide reductase activity is accompanied by a large increase in NADPH oxidase activity. J. Biol. Chem. 270:3479-3482; 1995.
122. Fang, J.; Holmgren, A. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo. J. Am. Chem. Soc. 128:1879-1885; 2006.
123. Cassidy, P. B.; Edes, K.; Nelson, C. C.; Parsawar, K.; Fitzpatrick, F. A.; Moos, P. J. Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles. Carcinogenesis 27:2538-2549; 2006.
124. Fang, J.; Lu, J.; Holmgren, A. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J. Biol. Chem. 280:25284-25290; 2005.
125. Nordberg, J.; Zhong, L.; Holmgren, A.; Arnér, E. S. Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue. J. Biol. Chem. 273:10835-10842; 1998.
126. Hojo, Y.; Satomi, Y. In vivo nephrotoxicity induced in mice by chromium(VI): involvement of glutathione and chromium(V). Biol. Trace Elem. Res. 31:21-31; 1991.
127. Bondareva, A. A.; Capecchi, M. R.; Iverson, S. V.; Li, Y.; Lopez, N. I.; Lucas, O.; Merrill, G. F.; Prigge, J. R.; Siders, A. M.; Wakamiya, M.; Wallin, S. L.; Schmidt, E. E. Effects of thioredoxin reductase-1 deletion on embryogenesis and transcriptome. Free Radic. Biol. Med. 43:911-923; 2007.
128. Anest̊al, K.; Arner, E. S. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine. J. Biol. Chem. 278:15966-15972; 2003.
129. Anest̊al, K.; Prast-Nielsen, S.; Cenas, N.; Arner, E. S. Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells. PLoS One 3:e1846; 2008.
130. Watson, W. H.; Heilman, J. M.; Hughes, L. L.; Spielberger, J. C. Thioredoxin reductase-1 knock down does not result in thioredoxin-1 oxidation. Biochem. Biophys. Res. Commun. 368:832-836; 2008.
131. Powis, G.; Montfort, W. R. Properties and biological activities of thioredoxins. Annu. Rev. Biophys. Biomol. Struct. 30:421-455; 2001.
132. Watson, W. H.; Pohl, J.; Montfort, W. R.; Stuchlik, O.; Reed, M. S.; Powis, G.; Jones, D. P. Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif. J. Biol. Chem. 278:33408-33415; 2003.
133. Myers, C. R.; Myers, J. M. The effects of acrolein on peroxiredoxins, thioredoxins, and thioredoxin reductase in human bronchial epithelial cells. Toxicology 257:95-104; 2009.
134. Szadkowski, A.; Myers, C. R. Acrolein oxidizes the cytosolic and mitochondrial thioredoxins in human endothelial cells. Toxicology 243:164-176; 2008.
135. Halvey, P. J.; Watson, W. H.; Hansen, J. M.; Go, Y. M.; Samali, A.; Jones, D. P. Compartmental oxidation of thiol-disulphide redox couples during epidermal growth factor signalling. Biochem. J. 386:215-219; 2005.
136. Alexander, J.; Aaseth, J.; Norseth, T. Uptake of chromium by rat liver mitochondria. Toxicology 24:115-122; 1982.
137. Rossi, S. C.; Gorman, N.; Wetterhahn, K. E. Mitochondrial reduction of the carcinogen chromate: formation of chromium(V). Chem. Res. Toxicol. 1:101-107; 1988.
138. Getz, E. B.; Xiao, M.; Chakrabarty, T.; Cooke, R.; Selvin, P. R. A comparison between the sulfhydryl reductants tris(2-carboxyethyl)phosphine and dithiothreitol for use in protein biochemistry. Anal. Biochem. 273:73-80; 1999.
139. Day, B. J.; Shawen, S.; Liochev, S. I.; Crapo, J. D. A metalloporphyrin superoxide dismutase mimetic protects against paraquat-induced endothelial cell injury, in vitro. J. Pharmacol. Exp. Ther. 275:1227-1232; 1995.
140. Liang, L. P.; Ho, Y. S.; Patel, M. Mitochondrial superoxide production in kainate-induced hippocampal damage. Neuroscience 101:563-570; 2000.
141. Milano, J.; Day, B. J. A catalytic antioxidant metalloporphyrin blocks hydrogen peroxide-induced mitochondrial DNA damage. Nucleic Acids Res. 28:968-973; 2000.
142. Melov, S.; Schneider, J. A.; Day, B. J.; Hinerfeld, D.; Coskun, P.; Mirra, S. S.; Crapo, J. D.; Wallace, D. C. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet. 18:159-163; 1998.
143. Malassagne, B.; Ferret, P. J.; Hammoud, R.; Tulliez, M.; Bedda, S.; Trebeden, H.; Jaffray, P.; Calmus, Y.; Weill, B.; Batteux, F. The superoxide dismutase mimetic MnTBAP prevents Fas-induced acute liver failure in the mouse. Gastroenterology 121:1451-1459; 2001.
144. Ye, J.; Zhang, X.; Young, H. A.; Mao, Y.; Shi, X. Chromium(VI)-induced nuclear factor-κB activation in intact cells via free radical reactions. Carcinogenesis 16:2401-2405; 1995.
145. 4mediates cellular responses via reactive oxygen species. Mol. Cell. Biochem. 255:171-179; 2004.
146. Qian, Y.; Jiang, B. H.; Flynn, D. C.; Leonard, S. S.; Wang, S.; Zhang, Z.; Ye, J.; Chen, F.; Wang, L.; Shi, X. Cr(VI) increases tyrosine phosphorylation through reactive oxygen species-mediated reactions. Mol. Cell. Biochem. 222:199-204; 2001.
147. 2+autoxidation: formation of spin adducts and their destruction by superoxide. Arch. Biochem. Biophys. 293:401-408; 1992.
148. Reinke, L. A.; Moore, D. R.; McCay, P. B. Degradation of DMPO adducts from hydroxyl and 1-hydroxyethyl radicals by rat liver microsomes. Free Radic. Res. 25:467-474; 1996.
149. Shi, H.; Timmins, G.; Monske, M.; Burdick, A.; Kalyanaraman, B.; Liu, Y.; Clement, J. L.; Burchiel, S.; Liu, K. J. Evaluation of spin trapping agents and trapping conditions for detection of cell-generated reactive oxygen species. Arch. Biochem. Biophys. 437:59-68; 2005.
150. Khan, N.; Wilmot, C. M.; Rosen, G. M.; Demidenko, E.; Sun, J.; Joseph, J.; O'Hara, J.; Kalyanaraman, B.; Swartz, H. M. Spin traps: in vitro toxicity and stability of radical adducts. Free Radic. Biol. Med. 34:1473-1481; 2003.
151. Nonn, L.; Williams, R. R.; Erickson, R. P.; Powis, G. The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol. Cell. Biol. 23:916-922; 2003.
152. Chen, Y.; Cai, J.; Jones, D. P. Mitochondrial thioredoxin in regulation of oxidant-induced cell death. FEBS Lett. 580:6596-6602; 2006.
153. Hansen, J. M.; Zhang, H.; Jones, D. P. Differential oxidation of thioredoxin-1, thioredoxin-2, and glutathione by metal ions. Free Radic. Biol. Med. 40:138-145; 2006.
154. Sun, Y.; Rigas, B. The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents. Cancer Res. 68:8269-8277; 2008.
155. Wood, Z. A.; Poole, L. B.; Karplus, P. A. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300:650-653; 2003.
156. Wood, Z. A.; Schroder, E.; Robin Harris, J.; Poole, L. B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28:32-40; 2003.
157. 2 is not reflected in its reaction with other oxidants and thiol reagents. J. Biol. Chem. 282:11885-11892; 2007.
158. Kim, J. A.; Park, S.; Kim, K.; Rhee, S. G.; Kang, S. W. Activity assay of mammalian 2-Cys peroxiredoxins using yeast thioredoxin reductase system. Anal. Biochem. 338:216-223; 2005.
159. Prigge, J. R.; Eriksson, S.; Iverson, S. V.; Meade, T. A.; Capecchi, M. R.; Arner, E. S.; Schmidt, E. E. Hepatocyte DNA replication in growing liver requires either glutathione or a single allele of txnrd1. Free Radic. Biol. Med. 52:803-810; 2012.
160. Chang, T. S.; Cho, C. S.; Park, S.; Yu, S.; Kang, S. W.; Rhee, S. G. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J. Biol. Chem. 279:41975-41984; 2004.
161. Cox, A. G.; Pullar, J. M.; Hughes, G.; Ledgerwood, E. C.; Hampton, M. B. Oxidation of mitochondrial peroxiredoxin 3 during the initiation of receptor- mediated apoptosis. Free Radic. Biol. Med. 44:1001-1009; 2008.
162. Cox, A. G.; Brown, K. K.; Arnér, E. S.; Hampton, M. B. The thioredoxin reductase inhibitor auranofin triggers apoptosis through a
163. Baty, J. W.; Hampton, M. B.; Winterbourn, C. C. Proteomic detection of hydrogen peroxide-sensitive thiol proteins in Jurkat cells. Biochem. J. 389:785-795; 2005.
164. Vásquez-Vivar, J.; Kalyanaraman, B.; Kennedy, M. C. Mitochondrial aconitase is a source of hydroxyl radical: an electron spin resonance investigation. J. Biol. Chem. 275:14064-14069; 2000.
165. Gardner, P. R. Superoxide-driven aconitase Fe-S center cycling. Biosci. Rep. 17:33-42; 1997.
166. Myers, C. R.; Myers, J. M. Iron stimulates the rate of reduction of hexavalent chromium by human microsomes. Carcinogenesis 19:1029-1038; 1998.
167. Reynolds, M.; Stoddard, L.; Bespalov, I.; Zhitkovich, A. Ascorbate acts as a highly potent inducer of chromate mutagenesis and clastogenesis: linkage to DNA breaks in G2 phase by mismatch repair. Nucleic Acids Res. 35:465-476; 2007.
168. Zhang, Y.; Marcillat, O.; Giulivi, C.; Ernster, L.; Davies, K. J. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem. 265:16330-16336; 1990.
169. Gardner, P. R.; Nguyen, D. D.; White, C. W. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc. Natl. Acad. Sci. USA 91:12248-12252; 1994.
170. Williams, M. D.; Van Remmen, H.; Conrad, C. C.; Huang, T. T.; Epstein, C. J.; Richardson, A. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J. Biol. Chem. 273:28510-28515; 1998.
171. Powell, C. S.; Jackson, R. M. Mitochondrial complex I, aconitase, and succinate dehydrogenase during hypoxia-reoxygenation: modulation of enzyme activities by MnSOD. Am. J. Physiol. Lung Cell. Mol. Physiol. 285:L189-L198; 2003.
172. Pearce, L. L.; Epperly, M. W.; Greenberger, J. S.; Pitt, B. R.; Peterson, J. Identification of respiratory complexes I and III as mitochondrial sites of damage following exposure to ionizing radiation and nitric oxide. Nitric Oxide 5:128-136; 2001.
173. Wang, D.; Masutani, H.; Oka, S.; Tanaka, T.; Yamaguchi-Iwai, Y.; Nakamura, H.; Yodoi, J. Control of mitochondrial outer membrane permeabilization and Bcl-xL levels by thioredoxin 2 in DT40 cells. J. Biol. Chem. 281:7384-7391; 2006.
174. Godley, B. F.; Shamsi, F. A.; Liang, F. Q.; Jarrett, S. G.; Davies, S.; Boulton, M. Blue light induces mitochondrial DNA damage and free radical production in epithelial cells. J. Biol. Chem. 280:21061-21066; 2005.
175. Yakes, F. M.; Van Houten, B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. USA 94:514-519; 1997.
176. Holmgren, A.; Lu, J. Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochem. Biophys. Res. Commun. 396:120-124; 2010.
177. Saitoh, M.; Nishitoh, H.; Fujii, M.; Takeda, K.; Tobiume, K.; Sawada, Y.; Kawabata, M.; Miyazono, K.; Ichijo, H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17:2596-2606; 1998.
178. Saxena, G.; Chen, J.; Shalev, A. Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein. J. Biol. Chem. 285:3997-4005; 2010.
179. Tobiume, K.; Saitoh, M.; Ichijo, H. Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer. J. Cell. Physiol. 191:95-104; 2002.
180. Ichijo, H.; Nishida, E.; Irie, K.; ten Dijke, P.; Saitoh, M.; Moriguchi, T.; Takagi, M.; Matsumoto, K.; Miyazono, K.; Gotoh, Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275:90-94; 1997.
181. Hatai, T.; Matsuzawa, A.; Inoshita, S.; Mochida, Y.; Kuroda, T.; Sakamaki, K.; Kuida, K.; Yonehara, S.; Ichijo, H.; Takeda, K. Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria-dependent caspase activation. J. Biol. Chem. 275:26576-26581; 2000.
182. Zhang, R.; Al-Lamki, R.; Bai, L.; Streb, J. W.; Miano, J. M.; Bradley, J.; Min, W. Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ. Res. 94:1483-1491; 2004.
183. Matsuzawa, A.; Ichijo, H. Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim. Biophys. Acta 1325-1336:2008; 1780.
184. Machino, T.; Hashimoto, S.; Maruoka, S.; Gon, Y.; Hayashi, S.; Mizumura, K.; Nishitoh, H.; Ichijo, H.; Horie, T. Apoptosis signal-regulating kinase 1-mediated signaling pathway regulates hydrogen peroxide-induced apoptosis in human pulmonary vascular endothelial cells. Crit. Care Med. 31:2776-2781; 2003.
185. Hoeflich, K. P.; Yeh, W. C.; Yao, Z.; Mak, T. W.; Woodgett, J. R. Mediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1). Oncogene 18:5814-5820; 1999.
186. Chen, Z.; Seimiya, H.; Naito, M.; Mashima, T.; Kizaki, A.; Dan, S.; Imaizumi, M.; Ichijo, H.; Miyazono, K.; Tsuruo, T. ASK1 mediates apoptotic cell death induced by genotoxic stress. Oncogene 18:173-180; 1999.
187. Chen, C. L.; Lin, C. F.; Chang, W. T.; Huang, W. C.; Teng, C. F.; Lin, Y. S. Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway. Blood 111:4365-4374; 2008.
188. Chen, F.; Ding, M.; Lu, Y.; Leonard, S. S.; Vallyathan, V.; Castranova, V.; Shi, X. Participation of MAP kinase p38 and IκB kinase in chromium(VI)-induced NF-κB and AP-1 activation. J. Environ. Pathol. Toxicol. Oncol. 19:231-238; 2000.
189. Samet, J. M.; Graves, L. M.; Quay, J.; Dailey, L. A.; Devlin, R. B.; Ghio, A. J.; Wu, W.; Bromberg, P. A.; Reed, W. Activation of MAPKs in human bronchial epithelial cells exposed to metals. Am. J. Physiol. (Lung Cell. Mol. Physiol.) 275:L551-L558; 1998.
190. Leonard, S. S.; Harris, G. K.; Shi, X. Metal-induced oxidative stress and signal transduction. Free Radic. Biol. Med. 37:1921-1942; 2004.
191. Tessier, D. M.; Pascal, L. E. Activation of MAP kinases by hexavalent chromium, manganese and nickel in human lung epithelial cells. Toxicol. Lett. 167:114-121; 2006.
192. O'Hara, K. A.; Klei, L. R.; Barchowsky, A. Selective activation of Src family kinases and JNK by low levels of chromium(VI). Toxicol. Appl. Pharmacol. 190:214-223; 2003.
193. Chuang, S. M.; Liou, G. Y.; Yang, J. L. Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity. Carcinogenesis 21:1491-1500; 2000.
194. Watjen, W.; Beyersmann, D. Cadmium-induced apoptosis in C6 glioma cells: influence of oxidative stress. BioMetals 17:65-78; 2004.
195. Bulavin, D. V.; Fornace Jr. A. J. p38 MAP kinase's emerging role as a tumor suppressor. Adv. Cancer Res. 92:95-118; 2004.
196. Rinna, A.; Forman, H. J. SHP-1 inhibition by 4-hydroxynonenal activates Jun N-terminal kinase and glutamate cysteine ligase. Am. J. Respir. Cell Mol. Biol. 39:97-104; 2008.
197. Dhanasekaran, D. N.; Reddy, E. P. JNK signaling in apoptosis. Oncogene 27:6245-6251; 2008.
198. Raman, M.; Chen, W.; Cobb, M. H. Differential regulation and properties of MAPKs. Oncogene 26:3100-3112; 2007.
199. Johnson, G. L.; Lapadat, R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911-1912; 2002.
200. Bulavin, D. V.; Demidov, O. N.; Saito, S.; Kauraniemi, P.; Phillips, C.; Amundson, S. A.; Ambrosino, C.; Sauter, G.; Nebreda, A. R.; Anderson, C. W.; Kallioniemi, A.; Fornace Jr A. J.; Appella, E. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat. Genet. 31:210-215; 2002.
201. Chai, W.; Liu, Z. p38 Mitogen-activated protein kinase mediates palmitate-induced apoptosis but not inhibitor of nuclear factor-B degradation in human coronary artery endothelial cells. Endocrinology 148:1622-1628; 2007.
202. Kim, B. J.; Ryu, S. W.; Song, B. J. JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J. Biol. Chem. 281:21256-21265; 2006.
203. Loesch, M.; Chen, G. The p38 MAPK stress pathway as a tumor suppressor or more? Front. Biosci. 13:3581-3593; 2008.
204. Zarubin, T.; Han, J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15:11-18; 2005.
205. Kwon, S. J.; Song, J. J.; Lee, Y. J. Signal pathway of hypoxia-inducible factor-1α phosphorylation and its interaction with von Hippel-Lindau tumor suppressor protein during ischemia in MiaPaCa-2 pancreatic cancer cells. Clin. Cancer Res. 11:7607-7613; 2005.
206. Wakeman, T. P.; Wyczechowska, D.; Xu, B. Involvement of the p38 MAP kinase in Cr(VI)-induced growth arrest and apoptosis. Mol. Cell. Biochem. 279:69-73; 2005.
207. Stern, R. M. Assessment of risk of lung cancer for welders. Arch. Environ. Health 38:148-155; 1983.
208. Chopra, P.; Kanoje, V.; Semwal, A.; Ray, A. Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases. Expert Opin. Invest. Drugs 17:1411-1425; 2008.
209. Mercer, B. A.; D'Armiento, J. M. Emerging role of MAP kinase pathways as therapeutic targets in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 1:137-150; 2006.
210. Khalil, N.; Xu, Y. D.; O'Connor, R.; Duronio, V. Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-β1- induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK. J. Biol. Chem. 280:43000-43009; 2005.
211. Gius, D.; Botero, A.; Shah, S.; Curry, H. A. Intracellular oxidation/reduction status in the regulation of transcription factors NF-κB and AP-1. Toxicol. Lett. 106:93-106; 1999.
212. Shaulian, E.; Karin, M. AP-1 in cell proliferation and survival. Oncogene 20:2390-2400; 2001.
213. Valko, M.; Morris, H.; Cronin, M. T. Metals, toxicity and oxidative stress. Curr. Med. Chem. 12:1161-1208; 2005.
214. Mossman, B. T.; Lounsbury, K. M.; Reddy, S. P. Oxidants and signaling by mitogen-activated protein kinases in lung epithelium. Am. J. Respir. Cell Mol. Biol. 34:666-669; 2006.
215. Abate, C.; Patel, L.; Rauscher III F. J.; Curran, T. Redox regulation of fos and jun DNA-binding activity in vitro. Science 249:1157-1161; 1990.
216. Hirota, K.; Matsui, M.; Iwata, S.; Nishiyama, A.; Mori, K.; Yodoi, J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA 94:3633-3638; 1997.
217. Chen, F.; Ding, M.; Castranova, V.; Shi, X. Carcinogenic metals and NF-κB activation. Mol. Cell. Biochem. 222:159-171; 2001.
218. Kim, Y. D.; An, S. C.; Oyama, T.; Kawamoto, T.; Kim, H. Oxidative stress, hogg1 expression and NF-κB activity in cells exposed to low level chromium. J. Occup. Health 45:271-277; 2003.
219. Wang, S.; Chen, F.; Zhang, Z.; Jiang, B. H.; Jia, L.; Shi, X. NF-κB prevents cells from undergoing Cr(VI)-induced apoptosis. Mol. Cell. Biochem. 255:129-137; 2004.
220. Chen, F.; Bower, J.; Leonard, S. S.; Ding, M.; Lu, Y.; Rojanasakul, Y.; Kung, H. F.; Vallyathan, V.; Castranova, V.; Shi, X. Protective roles of NF-κB for chromium(VI)-induced cytotoxicity is revealed by expression of IκB kinase-βmutant. J. Biol. Chem. 277:3342-3349; 2002.
221. Shumilla, J. A.; Broderick, R. J.; Wang, Y.; Barchowsky, A. Chromium(VI) inhibits the transcriptional activity of nuclear factor-κB by decreasing the interaction of p65 with cAMP-responsive element-binding protein-binding protein. J. Biol. Chem. 274:36207-36212; 1999.
222. Shumilla, J. A.; Wetterhahn, K. E.; Barchowsky, A. Inhibition of NF-κB binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism. Arch. Biochem. Biophys. 349:356-362; 1998.
223. Klaunig, J. E.; Kamendulis, L. M. The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 44:239-267; 2004.
224. Hansen, J. M.; Zhang, H.; Jones, D. P. Mitochondrial thioredoxin-2 has a key role in determining tumor necrosis factor-α-induced reactive oxygen species generation, NF-κB activation, and apoptosis. Toxicol. Sci. 91:643-650; 2006.
225. Hirota, K.; Murata, M.; Sachi, Y.; Nakamura, H.; Takeuchi, J.; Mori, K.; Yodoi, J. Distinct roles of thioredoxin in the cytoplasm and in the nucleus: a twostep mechanism of redox regulation of transcription factor NF-κB. J. Biol. Chem. 274:27891-27897; 1999.
226. Matthews, J. R.; Wakasugi, N.; Virelizier, J. L.; Yodoi, J.; Hay, R. T. Thioredoxin regulates the DNA binding activity of NF-κB by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 20:3821-3830; 1992.
227. 2-terminal kinase-mediated redox-dependent degradation of IκB: role of thioredoxin in NF-κB activation. J. Biol. Chem. 276:4662-4670; 2001.
228. Horton, N. D.; Biswal, S. S.; Corrigan, L. L.; Bratta, J.; Kehrer, J. P. Acrolein causes inhibitor κB-independent decreases in nuclear factor κB activation in human lung adenocarcinoma (A549) cells. J. Biol. Chem. 274:9200-9206; 1999.
229. Ueno, H.; Kajihara, H.; Nakamura, H.; Yodoi, J.; Nakamuro, K. Contribution of thioredoxin reductase to T-cell mitogenesis and NF-κB DNA-binding promoted by selenite. Antioxid. Redox Signaling 9:115-121; 2007.
230. Kim, D. H.; Kundu, J. K.; Surh, Y. J. Redox modulation of p53: mechanisms and functional significance. Mol. Carcinog. 50:222-234; 2011.
231. Shen, H.; Maki, C. G. Pharmacologic activation of p53 by small-molecule MDM2 antagonists. Curr. Pharm. Des. 17:560-568; 2011.
232. Wu, G. S. The functional interactions between the p53 and MAPK signaling pathways. Cancer Biol. Ther. 3:156-161; 2004.
233. Ueno, M.; Masutani, H.; Arai, R. J.; Yamauchi, A.; Hirota, K.; Sakai, T.; Inamoto, T.; Yamaoka, Y.; Yodoi, J.; Nikaido, T. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J. Biol. Chem. 274:35809-35815; 1999.
234. Russo, P.; Catassi, A.; Cesario, A.; Imperatori, A.; Rotolo, N.; Fini, M.; Granone, P.; Dominioni, L. Molecular mechanisms of hexavalent chromium-induced apoptosis in human bronchoalveolar cells. Am. J. Respir. Cell Mol. Biol. 33:589-600; 2005.
235. Yao, H.; Guo, L.; Jiang, B. H.; Luo, J.; Shi, X. Oxidative stress and chromium(VI) carcinogenesis. J. Environ. Pathol. Toxicol. Oncol. 27:77-88; 2008.
236. Carlisle, D. L.; Pritchard, D. E.; Singh, J.; Patierno, S. R. Chromium(VI) induces p53-dependent apoptosis in diploid human lung and mouse dermal fibroblasts. Mol. Carcinog. 28:111-118; 2000.
237. Wang, S.; Shi, X. Mechanisms of Cr(VI)-induced p53 activation: the role of phosphorylation, mdm2 and ERK. Carcinogenesis 22:757-762; 2001.
238. Gambelunghe, A.; Piccinini, R.; Abbritti, G.; Ambrogi, M.; Ugolini, B.; Marchetti, C.; Migliorati, G.; Balducci, C.; Muzi, G. Chromium VI-induced apoptosis in a human bronchial epithelial cell line (BEAS-2B) and a lymphoblastic leukemia cell line (MOLT-4). J. Occup. Environ. Med. 48:319-325; 2006.
239. Ceryak, S.; Zingariello, C.; O'Brien, T.; Patierno, S. R. Induction of proapoptotic and cell cycle-inhibiting genes in chromium (VI)-treated human lung fibroblasts: lack of effect of ERK. Mol. Cell. Biochem. 255:139-149; 2004.
240. Fuchs, S. Y.; Adler, V.; Pincus, M. R.; Ronai, Z. MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. USA 95:10541-10546; 1998.
241. Piccirillo, S.; Filomeni, G.; Brune, B.; Rotilio, G.; Ciriolo, M. R. Redox mechanisms involved in the selective activation of Nrf2-mediated resistance versus p53-dependent apoptosis in adenocarcinoma cells. J. Biol. Chem. 284:27721-27733; 2009.
242. Ditch, S.; Paull, T. T. The ATM protein kinase and cellular redox signaling: beyond the DNA damage response. Trends Biochem. Sci. 37:15-22; 2012.
243. Ha, L.; Ceryak, S.; Patierno, S. R. Chromium(VI) activates ataxia telangiectasia mutated (ATM) protein: requirement of ATM for both apoptosis and recovery from terminal growth arrest. J. Biol. Chem. 278:17885-17894; 2003.
244. Moos, P. J.; Edes, K.; Cassidy, P.; Massuda, E.; Fitzpatrick, F. A. Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase. J. Biol. Chem. 278:745-750; 2003.
245. Kaspar, J. W.; Niture, S. K.; Jaiswal, A. K. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic. Biol. Med. 47:1304-1309; 2009.
246. Keum, Y. S. Regulation of the Keap1/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modifications. Ann. N. Y. Acad. Sci. 1229:184-219; 2011.
247. Nguyen, T.; Yang, C. S.; Pickett, C. B. The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic. Biol. Med. 37:433-441; 2004.
248. 2 involves KEAP1 disulfide formation. J. Biol. Chem. 285:8463-8471; 2010.
249. He, X.; Lin, G. X.; Chen, M. G.; Zhang, J. X.; Ma, Q. Protection against chromium(VI)-induced oxidative stress and apoptosis by Nrf2: recruiting Nrf2 into the nucleus and disrupting the nuclear Nrf2/Keap1 association. Toxicol. Sci. 98:298-309; 2007.
250. Suvorova, E. S.; Lucas, O.; Weisend, C. M.; Rollins, M. F.; Merrill, G. F.; Capecchi, M. R.; Schmidt, E. E. Cytoprotective Nrf2 pathway is induced in chronically txnrd 1-deficient hepatocytes. PLoS One 4:e6158; 2009.
251. Imhoff, B. R.; Hansen, J. M. Extracellular redox status regulates Nrf2 activation through mitochondrial reactive oxygen species. Biochem. J. 424:491-500; 2009.
252. Imhoff, B. R.; Hansen, J. M. Tert-butylhydroquinone induces mitochondrial oxidative stress causing Nrf2 activation. Cell Biol. Toxicol. 26:541-551; 2010.
253. Hansen, J. M.; Watson, W. H.; Jones, D. P. Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol. Sci. 82:308-317; 2004.
254. Izzotti, A.; Cartiglia, C.; Balansky, R.; D'Agostini, F.; Longobardi, M.; De Flora, S. Selective induction of gene expression in rat lung by hexavalent chromium. Mol. Carcinog. 35:75-84; 2002.
255. Niso-Santano, M.; Gonzalez-Polo, R. A.; Bravo-San Pedro, J. M.; Gomez-Sanchez, R.; Lastres-Becker, I.; Ortiz-Ortiz, M. A.; Soler, G.; Moran, J. M.; Cuadrado, A.; Fuentes, J. M. Activation of apoptosis signal-regulating kinase 1 is a key factor in paraquat-induced cell death: modulation by the Nrf2/Trx axis. Free Radic. Biol. Med. 48:1370-1381; 2010.
256. Chew, E. H.; Nagle, A. A.; Zhang, Y.; Scarmagnani, S.; Palaniappan, P.; Bradshaw, T. D.; Holmgren, A.; Westwell, A. D. Cinnamaldehydes inhibit thioredoxin reductase and induce Nrf2: potential candidates for cancer therapy and chemoprevention. Free Radic. Biol. Med. 48:98-111; 2010.
257. Eriksson, S. E.; Prast-Nielsen, S.; Flaberg, E.; Szekely, L.; Arnér, E. S. High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy. Free Radic. Biol. Med. 47:1661-1671; 2009.
258. Hu, L.; Miao, W.; Loignon, M.; Kandouz, M.; Batist, G. Putative chemopreventive molecules can increase Nrf2-regulated cell defense in some human cancer cell lines, resulting in resistance to common cytotoxic therapies. Cancer Chemother. Pharmacol. 66:467-474; 2010.
259. Ye, J.; Shi, X. Gene expression profile in response to chromium-induced cell stress in A549 cells. Mol. Cell. Biochem. 222:189-197; 2001.
260. O'Hara, K. A.; Nemec, A. A.; Alam, J.; Klei, L. R.; Mossman, B. T.; Barchowsky, A. Chromium(VI) inhibits heme oxygenase-1 expression in vivo and in arsenic-exposed human airway epithelial cells. J. Cell. Physiol. 209:113-121; 2006.
261. Kosmider, B.; Messier, E. M.; Chu, H. W.; Mason, R. J. Human alveolar epithelial cell injury induced by cigarette smoke. PLoS One 6:e26059; 2011.
262. Reddy, N. M.; Potteti, H. R.; Mariani, T. J.; Biswal, S.; Reddy, S. P. Conditional deletion of Nrf2 in airway epithelium exacerbates acute lung injury and impairs the resolution of inflammation. Am. J. Respir. Cell Mol. Biol. 45:1161-1168; 2011.
263. Rubio, V.; Zhang, J.; Valverde, M.; Rojas, E.; Shi, Z. Z. Essential role of Nrf2 in protection against hydroquinone- and benzoquinone-induced cytotoxicity. Toxicol. in Vitro 25:521-529; 2011.